Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666393 | SCV000790678 | pathogenic | Fanconi anemia complementation group A | 2017-04-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530683 | SCV002976221 | pathogenic | Fanconi anemia | 2022-08-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 551354). This premature translational stop signal has been observed in individual(s) with Fanconi anemia (PMID: 21273304). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln240*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). |
Baylor Genetics | RCV000666393 | SCV004196061 | pathogenic | Fanconi anemia complementation group A | 2023-08-09 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000666393 | SCV001425632 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Daniela Pilonetto, Johan de Winter. |